(Press-News.org) Philadelphia, August 22, 2024 – There is a critical unmet need to help tighten and maintain a healthy intestinal barrier and treat a leaky gut. Researchers have now found that a unique strain of probiotic bacteria, Bifidobacterium bifidum BB1, enhances intestinal barrier function and protects against penetration of bacteria and various harmful agents in the intestine. The findings, detailed in an article in The American Journal of Pathology, published by Elsevier, can help advance the development of novel, targeted, naturally occurring probiotic therapy for patients with inflammatory bowel disease (IBD) and other inflammatory diseases, such as fatty liver disease or alcoholic liver disease, that are associated with a leaky or disordered intestinal barrier.
Lead investigator Thomas Y. Ma, MD, PhD, Penn State College of Medicine, Hershey Medical Center, explains, "There is a critical need to develop nontoxic, patient-friendly, naturally occurring products such as probiotics for treatment of IBD and other inflammatory diseases associated with leaky gut. Our studies suggest that BB1 is such a precision probiotic strain; it has the unique biological activity to produce maximal intestinal barrier enhancement and also protect against the activation of inflammation."
Patients with active IBD have elevated proinflammatory cytokines, including tumor necrosis factor (TNF)-α and IL1β. TNF-α levels are markedly elevated in intestinal tissue, serum, and stool of patients with IBD and at elevated levels produce an increase in intestinal tight junction permeability. TNF-α plays a central role in promoting intestinal inflammation in patients with IBD, and anti–TNF-α antibodies are highly effective in the treatment of the active disease. Previous studies from the laboratory at Penn State College of Medicine have shown that BB1 caused a marked enhancement of the intestinal epithelial barrier function and protects against the development of dextran sulfate sodium–induced intestinal inflammation.
Dr. Ma adds, "Our results show that BB1 prevented the TNF-α increase in intestinal tight junction permeability via a toll-like receptor (TLR)-2 signal transduction pathway inhibition of NF-kB p50/p65 activation and MLCK gene. We also found that a protein called PPAR-γ was a critical intestinal cell mediator that regulated the intestinal barrier protection. Treatment of patients with active ulcerative colitis with a PPAR-γ agonist, rosiglitazone, significantly reduced the ulcerative colitis disease activity index score and resulted in an improved quality of life."
Dr. Ma concludes, "These studies unravel novel intracellular mechanisms of BB1, a unique probiotic bacterial strain, demonstrating the promise of promoting health and treating inflammatory diseases including inflammatory bowel disease by maintaining a healthy intestinal barrier and protecting against leaky gut or intestinal barrier disruption."
IBD, which includes Crohn’s disease and ulcerative colitis, is characterized by inflammation affecting the gastrointestinal tract. The defective intestinal epithelial tight junction barrier is an important pathogenic factor contributing to the development of IBD. Patients with IBD have a defective intestinal tight junction barrier, characterized by increased intestinal permeability and increased luminal antigen penetration. Intestinal epithelial cells cover the entire intestinal mucosal surface and serve as a physical and functional barrier against the intestinal permeation of noxious luminal substances, including bacterial antigens, toxins, digestive enzymes, and food by-products.
END
A potential pathway may guide new therapies for inflammatory bowel disease and other inflammatory diseases
Study in The American Journal of Pathology finds unique strain of probiotic Bifidobacterium bifidum strengthens intestinal barrier function and protects against harmful bacterial and noxious agents associated with a leaky or disordered intestinal barrier
2024-08-22
ELSE PRESS RELEASES FROM THIS DATE:
CU researchers awarded $1.35 million grant to develop decision support technology for long-term care facilities
2024-08-22
Researchers from the University of Colorado College of Nursing and CU School of Medicine on the Anschutz Medical Campus were awarded a $1.35 million grant from the Agency for Healthcare Research and Quality (AHRQ) to design and implement technologies that improve resident safety and employee wellbeing at long-term care facilities.
“Long-term care facilities in the United States are in crisis, they’re facing low resources and high staff turnover,” CU Nursing Associate Professor and ...
Alzheimer’s drug may someday help save lives by inducing a state of “suspended animation”
2024-08-22
Researchers at the Wyss Institute for Biologically Inspired Engineering at Harvard University report that they were able to successfully put tadpoles of Xenopus laevis frogs into a hibernation-like torpor state using donepezil (DNP), a drug approved by the FDA to treat Alzheimer’s. The team had previously used another drug, SNC80, to achieve similar results in tadpoles and enhance the survival of whole mammalian hearts for transplants, but SNC80 is not approved for clinical use in humans because it can cause seizures. By contrast, DNP is already being used in the clinic, meaning it potentially could be rapidly repurposed ...
New NSF Center for Pandemic Insights
2024-08-22
Preventing the next pandemic begins before diseases emerge. This “pre-emergence” phase is the focus of a new center funded by the U.S. National Science Foundation and led by the University of California, Davis.
Supported with $18 million over seven years, the U.S. National Science Foundation Center for Pandemic Insights (NSF CPI) includes partnering institutions from across the United States. It aims to harness new technologies and develop sensing to detect, investigate, and ultimately prevent ...
FAMU-FSU College of Engineering research shows how insulin, zinc and pH can block harmful protein clumps linked to Type 2 diabetes
2024-08-22
An estimated 462 million people around the world suffer from Type 2 diabetes, a chronic disease in which the body has problems using sugar as a fuel, leading to a buildup of sugar in the blood and chronic health issues.
New research led by Ayyalusamy Ramamoorthy, a professor at the FAMU-FSU College of Engineering and the Florida State University-headquartered National High Magnetic Field Laboratory, shows how zinc, pH levels and insulin work together to inhibit the buildup of protein clumps that contribute to this disease. The work, which points toward promising avenues for innovative treatments, ...
Fecal, blood, and urinary biomarkers in inflammatory bowel diseases
2024-08-22
The global burden of inflammatory bowel diseases (IBD), primarily Crohn's disease (CD) and ulcerative colitis (UC), continues to rise. Recent data show incidence rates of up to 17.8 cases per 100,000 person-years for CD and even higher for UC, reaching 28.4 per 100,000 person-years. These diseases primarily affect older populations and vary geographically, with higher prevalence rates in highly developed countries. Currently, endoscopic assessment through ileo-colonoscopy is the gold standard for diagnosing and monitoring IBD. However, this approach is invasive and often has limited availability, leading to long ...
ARDD 2024 | What can we do before the "cliff" of aging arrives?
2024-08-22
When exactly does the aging process start? With the aging mechanisms unclear, no consensus has been reached about aging “cliffs”, where our body functions and biological processes just change dramatically, as if overnight.
In 2019, a study published in the authoritative peer-reviewed journal Nature Medicine, based on plasma proteomics data, identified 34, 60, and 78 years old as key time points of aging. In August 2024, Nature Aging, a Nature portfolio journal focusing on aging mechanisms, published the latest findings incorporating comprehensive data including transcriptomics and metabolomics, pinpointing the aging cliffs to the 40s and 60s.
In the biomedical field, multi-omics ...
Hydrogels can play Pong by “remembering” previous patterns of electrical simulation
2024-08-22
Non-living hydrogels can play the video game Pong and improve their gameplay with more experience, researchers report August 23 in the Cell Press journal Cell Reports Physical Science. The researchers hooked hydrogels up to a virtual game environment and then applied a feedback loop between the hydrogel’s paddle—encoded by the distribution of charged particles within the hydrogel—and the ball’s position—encoded by electrical stimulation. With practice, the hydrogel’s accuracy improved by up to 10%, resulting in longer rallies. The researchers say that this demonstrates ...
Precision drug olaparib may be effective without hormone therapy for some men with biochemically recurrent prostate cancer
2024-08-22
The anti-cancer drug olaparib may be effective in treating biochemically recurrent prostate cancer without accompanying hormone therapy for men who have mutations in genes such as BRCA2, according to results of a phase II clinical trial of 51 patients conducted at the Johns Hopkins Kimmel Cancer Center and three other sites.
The study was done of men experiencing signs of cancer recurrence after surgical removal of the prostate, as measured by a high level of the protein prostate-specific antigen (PSA). Following treatment with olaparib, 13 participants, including all 11 who had BRCA2 mutations, had a decrease in PSA of at least 50% ...
Americans face disparities in exposure to tobacco on streaming platforms
2024-08-22
Tens of millions of Americans are being exposed to tobacco content on streaming services, according to new research from The University of Texas MD Anderson Cancer Center. The researchers found that the odds of encountering tobacco products being advertised, marketed or promoted on these platforms increased based on race, ethnicity, socioeconomic status and smoking habits.
The nationally representative study, published today in JAMA Network, revealed an estimated 12.4% of American adults were exposed to tobacco promotion on streaming services. Exposure was highest among those with a high school education or less (16.4%), Black/African American respondents (19.4%), ...
Elinzanetant for the treatment of vasomotor symptoms associated with menopause
2024-08-22
About The Study: In two pivotal phase 3 clinical trials, elinzanetant, a selective neurokinin-1,3 receptor antagonist, demonstrated statistically significant reductions in vasomotor symptoms (VMS) frequency and severity vs placebo in postmenopausal individuals with moderate to severe VMS. Elinzanetant also significantly improved sleep disturbances and menopause-related quality of life vs placebo; the safety profile was favorable.
Corresponding Author: To contact the corresponding author, JoAnn V. Pinkerton, ...
LAST 30 PRESS RELEASES:
$3.5M grant to Georgia State will fuel space research across the globe
Polar molecules dance to the tunes of microwaves
Quantum researchers cause controlled ‘wobble’ in the nucleus of a single atom
Foods with low Nutri-Scores associated with an increased risk of cardiovascular diseases
Research reveals reality of Ice Age teen puberty
Use of biomarkers in the management of inflammatory bowel disease
Powered by renewable energy, microbes turn CO2 into protein and vitamins
Scientists aim to decode the genetic roots of mental illness on a large scale
Retinopathy associated with hair dye
Race, social determinants of health, and the quality of diabetic eye care
Molecular, socioeconomic, and clinical factors affecting racial and ethnic disparities in colorectal cancer survival
City of Hope and Biopharmaceutical Research Company announce first patient has received BRC-001, a first-in-class cannabinoid therapeutic, in a clinical trial investigating supportive care in breast c
Catalyzing environmental cleanup: A highly active and selective molecular catalyst and electrified membrane
Dual-feedback healing mechanism redefining anti-oxidation coatings in fiber reinforced composites
NCCN commits to sharing award-winning resources for people with cancer in Spanish and other languages
Development strategies for using carbon-based catalysts in CO2 conversion
Breakthrough research extends hope for gastric cancer patients with peritoneal metasis
Genetic carriers for sickle cell disease have higher risks of blood clots across diverse ancestries
Study finds unique pattern of blood clots in sickle cell trait, but low overall clot risk
Deep learning for strain field customization in bioreactor with dielectric elastomer actuator array
Killer yeasts may help remedy a craft beer brewing bother
Nationwide awards recognize 21 students, schools and educators’ commitment to health
Bake, melt or ignite: How synthesis methods have a profound impact on disordered materials
A majority of Americans can’t recall most First Amendment rights
2024 Blavatnik National Awards for Young Scientists announced
TTUHSC’s Jerry H. Hodge School of Pharmacy establishes Brain Drug Discovery Center
Collaborative three-campus QB3 research team awarded $12 million CIRM grant to study origins of autism in diverse population
Cannabis and older adults: Poll shows current use patterns, beliefs and risks
Dr. Baptiste Lacoste, of the Ottawa Hospital Research Institute and uOttawa Brain and Mind Research Institute, receives a SynGAP Research Fund (SRF) Grant for Groundbreaking Research on Vascular and M
$75,000 prize inspired by 18th century Scots economist attracts global entries
[Press-News.org] A potential pathway may guide new therapies for inflammatory bowel disease and other inflammatory diseasesStudy in The American Journal of Pathology finds unique strain of probiotic Bifidobacterium bifidum strengthens intestinal barrier function and protects against harmful bacterial and noxious agents associated with a leaky or disordered intestinal barrier